Antonio Augusto Fidalgo

Dr. Antonio Augusto Fidalgo

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2023 in Viruses
Verified
Journal Article
Open access
PDF file
RRRodrigo Nunes Rodrigues-da-Silva
Rodrigo Nunes Rodrigues-da-Silva
FCFernando Conte
Fernando Conte
GSGustavo da Silva
Gustavo da Silva
ACAna L. Carneiro-Alencar
Ana L. Carneiro-Alencar
PGPaula R. Gomes
Paula R. Gomes
JLJosué da Costa Lima-Junior
Josué da Costa Lima-Junior
The Nucleocapsid (N) protein is highlighted as the main target for COVID-19 diagnosis by antigen detection due to its abundance in circulation early during infection. However, the effects of the described mutations in the N protein epitopes and the efficacy of antigen testing across SARS-CoV-2 variants remain controversial and poorly understood. Here, we used immunoinformatics to identify five epitopes in the SARS-CoV-2 N protein (N(34–48), N(89–104), N(185–197), N(277–287), and N(378–390)) and validate their reactivity against samples from COVID-19 convalescent patients. All identified epitopes are fully conserved in the main SARS-CoV-2 variants and highly conserved with SARS-CoV. Moreover, the epitopes N(185–197) and N(277–287) are highly conserved with MERS-CoV, while the epitopes N(34–48), N(89–104), N(277–287), and N(378–390) are lowly conserved with common cold coronaviruses (229E, NL63, OC43, HKU1). These data are in accordance with the observed conservation of amino acids recognized by the antibodies 7R98, 7N0R, and 7CR5, which are conserved in the SARS-CoV-2 variants, SARS-CoV and MERS-CoV but lowly conserved in common cold coronaviruses. Therefore, we support the antigen tests as a scalable solution for the population-level diagnosis of SARS-CoV-2, but we highlight the need to verify the cross-reactivity of these tests against the common cold coronaviruses.

20 September 2018 in Revista Fitos
Verified
Journal Article
Open access
PDF file
RGRachel Novaes Gomes
Rachel Novaes Gomes
PLPaula Siqueira Lima
Paula Siqueira Lima
SKSergio Noboru Kuriyama
Sergio Noboru Kuriyama
AFAntonio Augusto Fidalgo
Antonio Augusto Fidalgo
A preocupação com as questões ambientais tem influenciado diretamente o desenvolvimento de novas tecnologias. A busca por um desenvolvimento sustentável tem levado a busca por metodologias que empreguem o conceito de Química Verde nos diferentes setores das Indústrias Brasileiras. Nesta revisão, fazemos um breve relato da aplicação da Química verde no setor industrial Brasileiro.

9 February 2022 in Frontiers in Microbiology
Verified
Journal Article
Open access
BHBianca Monteiro Henriques-Santos
Bianca Monteiro Henriques-Santos
BFBruna Farjun
Bruna Farjun
ICIsadora Alonso Corrêa
Isadora Alonso Corrêa
JFJanaina de Barros Figueiredo
Janaina de Barros Figueiredo
AFAntonio Augusto Fidalgo
Antonio Augusto Fidalgo
SKSergio Noboru Kuriyama
Sergio Noboru Kuriyama
Since the first reported case in December 2019, SARS-CoV-2 infections have become a major public health worldwide. Even with the increasing vaccination in several countries and relaxing of social distancing measures, the pandemic remains a threat especially due to the emergence of new SARS-CoV-2 variants. Despite the presence of an enzyme capable of proofreading its genome, high rates of replication provide a source of accumulation of mutations within the viral genome. In this retrospective study, samples from a cohort of industry workers tested by the SESI’s COVID-19 mass testing program from September 2020 to May 2021 were analyzed using a mutation panel in order to describe the circulation of currently identified SARS-CoV-2 variants within the samples obtained in Rio de Janeiro State. Our results demonstrated that the variant of interest (VOI) Zeta has been in circulation since October 2020 and reached 87% of prevalence in February 2021 followed by a decrease due to the emergence of Gamma variant of concern (VOC). Gamma was detected in January 2021 in our studied population, and its prevalence increased during the following months, reaching absolute prevalence within positive samples in May. The Alpha variant was detected only in 4–7% of samples during March and April while Beta VOC was not detected in our study. Our data agree with sequencing genomic surveillance databases and highlight the importance of continuous mass testing programs and variant detection in order to control viral spread and guide public health measures.

23 May 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ICIsadora Alonso Correa
Isadora Alonso Correa
TRTamires de Souza Rodrigues
Tamires de Souza Rodrigues
AQAlex Queiroz
Alex Queiroz
LNLeon de França Nascimento
Leon de França Nascimento
TWThiago Wolff
Thiago Wolff
AFAntonio Augusto Fidalgo
Antonio Augusto Fidalgo
RT-qPCR is the gold standard technique available for SARS-CoV-2 detection. However, the long test run time and costs associated with this type of molecular testing are a challenge in a pandemic scenario. Due to high testing demand, especially for monitoring highly vaccinated populations facing the emergence of new SARS-CoV-2 variants, strategies that allow the increase in testing capacity and cost savings are needed. We evaluated a RT-qPCR pooling strategy either as a simplex and multiplex assay, as well as performed in-silico statistical modeling analysis validated with specimen samples obtained from a mass testing program of Industry Federation of the State of Rio de Janeiro (Brazil). Although the sensitivity reduction in samples pooled with 32 individuals in a simplex assay was observed, the high-test sensitivity was maintained even when 16 and 8 samples were pooled. This data was validated with the results obtained in our mass testing program with a cost saving of 51.5% already considering the expenditures with pool sampling that were analyzed individually. We also demonstrated that the pooling approach using 4 or 8 samples tested with a triplex combination in RT-qPCR is feasible to be applied without sensitivity loss, mainly combining Nucleocapsid (N) and Envelope (E) gene targets. Our data shows that the combination of pooling in a RT-qPCR multiplex assay could strongly contribute to mass testing programs with high-cost savings and low-reagent consumption while maintaining test sensitivity. In addition, the test capacity is predicted to be considerably increased which is fundamental for the control of the virus spread in the actual pandemic scenario.

19 August 2020 in medRxiv
Verified
Preprint
Open access
PDF file
ICIsadora Alonso Correa
Isadora Alonso Correa
TRTamires de Souza Rodrigues
Tamires de Souza Rodrigues
AQAlex Queiroz
Alex Queiroz
LNLeon de França Nascimento
Leon de França Nascimento
TWThiago Wolff
Thiago Wolff
AFAntonio Augusto Fidalgo
Antonio Augusto Fidalgo
QRT-PCR is the gold standard technique available for SARS-CoV-2 detection. However, the long test run time and costs associated with this type of molecular testing are a challenge in the actual pandemic scenario. Due to high testing demand, pooling sample strategy is an interesting approach to allow cost savings. We aim to evaluate pooling tests in experimental procedures, as well as perform in silico statistical modeling analysis validated with specimen samples obtained from a mass testing program of Industry Federation of the State of Rio de Janeiro (Brazil). Although the sensitivity reduction in samples pooled with 32 individuals was observed, the high-test sensitivity is maintained even when 16 and 8 samples were pooled. The in silico analysis showed high-cost savings in populations with positive rates lower than 15.0% according to the pool size. This data was validated with the results obtained in our mass testing program: statistical modeling predicted a cost saving of 48.0%, which in practice, was 51.5%, already considering the expenditures with pool sampling that were analyzed individually. Our data confirmed that mathematical modeling is a powerful strategy to improve the pooling approach for SARS-CoV-2 mass testing around the world while maintaining high sensitivity and robustness.

11 April 2023 in OBSERVATÓRIO DE LA ECONOMÍA LATINOAMERICANA
Verified
Journal Article
Open access
PDF file
RCRaquel Bernardo Nana De Castro
Raquel Bernardo Nana De Castro
CRCarolyne Pimentel Rosado
Carolyne Pimentel Rosado
RSRodrigo Gonçalves Gusmão De Souza
Rodrigo Gonçalves Gusmão De Souza
LSLuciana de Oliveira Silva
Luciana de Oliveira Silva
OFOtniel Freitas-Silva
Otniel Freitas-Silva
Anderson Junger TeodoroAnderson Junger Teodoro
Anderson Junger Teodoro
Prostate cancer is the most frequent and lethal neoplastic disease among men worldwide. There is growing interest in the biologically active compounds in coffee for their potential chemopreventive. The present study aimed to analyze the content of bioactive compounds, the antioxidant and antiproliferative activity of green arabica coffee and different roasts extracted by supercritical fluid. The concentration of caffeine, chlorogenic acid and caffeic acid were evaluated. Additionally, the colorimetric profile, antioxidant capacity, effect on cell viability, cell cycle and apoptosis of the extracts. Caffeine, caffeic acid and chlorogenic acid content were higher in green coffee extract than in roasted coffee (80.0mg/100g, 16.76 and 19.37mg/mL, respectively). The green coffee extract showed higher antioxidant activity and total phenolic content compared to the other coffee extracts by all methods tested; and among the roasted coffee extracts, light roast coffee stands out with the highest antioxidant capacity. After 48 hours of treatment, coffee extracts caused a reduction in the viability of PC-3 cells, with light roast coffee being more effective. Green and light roast coffee extracts induced a cell cycle arrest in the S phase and increased apoptosis. The present results strongly suggest that coffee extracts have an antiproliferative effect on prostate adenocarcinoma cells.